1. Home
  2. BNTC vs MGYR Comparison

BNTC vs MGYR Comparison

Compare BNTC & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • MGYR
  • Stock Information
  • Founded
  • BNTC 1995
  • MGYR 1922
  • Country
  • BNTC United States
  • MGYR United States
  • Employees
  • BNTC N/A
  • MGYR N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • MGYR Savings Institutions
  • Sector
  • BNTC Health Care
  • MGYR Finance
  • Exchange
  • BNTC Nasdaq
  • MGYR Nasdaq
  • Market Cap
  • BNTC 88.1M
  • MGYR 94.2M
  • IPO Year
  • BNTC N/A
  • MGYR 2006
  • Fundamental
  • Price
  • BNTC $11.82
  • MGYR $14.26
  • Analyst Decision
  • BNTC Buy
  • MGYR
  • Analyst Count
  • BNTC 6
  • MGYR 0
  • Target Price
  • BNTC $23.83
  • MGYR N/A
  • AVG Volume (30 Days)
  • BNTC 52.1K
  • MGYR 7.5K
  • Earning Date
  • BNTC 02-11-2025
  • MGYR 01-23-2025
  • Dividend Yield
  • BNTC N/A
  • MGYR 1.67%
  • EPS Growth
  • BNTC N/A
  • MGYR 2.51
  • EPS
  • BNTC N/A
  • MGYR 1.23
  • Revenue
  • BNTC N/A
  • MGYR $31,497,000.00
  • Revenue This Year
  • BNTC N/A
  • MGYR N/A
  • Revenue Next Year
  • BNTC N/A
  • MGYR N/A
  • P/E Ratio
  • BNTC N/A
  • MGYR $11.45
  • Revenue Growth
  • BNTC N/A
  • MGYR 4.87
  • 52 Week Low
  • BNTC $2.69
  • MGYR $10.30
  • 52 Week High
  • BNTC $13.29
  • MGYR $14.74
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 62.51
  • MGYR 61.99
  • Support Level
  • BNTC $11.36
  • MGYR $14.08
  • Resistance Level
  • BNTC $13.29
  • MGYR $14.57
  • Average True Range (ATR)
  • BNTC 0.96
  • MGYR 0.32
  • MACD
  • BNTC 0.23
  • MGYR -0.03
  • Stochastic Oscillator
  • BNTC 86.05
  • MGYR 75.51

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

Share on Social Networks: